Genomics BioSci & Tech. Co.,Ltd. announced earnings results for the full year ended December 31, 2019. For the full year, the company announced sales was TWD 427.652 million compared to TWD 375.393 million a year ago. Operating income was TWD 8.491 million compared to operating loss of TWD 40.963 million a year ago. Net income was TWD 84.936 million compared to net loss of TWD 60.549 million a year ago. Basic earnings per share from continuing operations was TWD 0.32 compared to basic loss per share from continuing operations of TWD 0.62 a year ago. Basic earnings per share was TWD 1.47 compared to basic loss per share of TWD 1.05 a year ago. Diluted earnings per share from continuing operations was TWD 0.31 compared to diluted loss per share from continuing operations of TWD 0.62 a year ago. Diluted earnings per share was TWD 1.46 compared to diluted loss per share of TWD 1.05 a year ago.